Hydroxyzine Pamoate
NDC 0555-0324, Hydroxyzine Pamoate, capsule, from Teva Pharmaceuticals USA, Inc..
- Product NDC
- 0555-0324
- Status
- Listed
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA088488
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0555-0324 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- HYDROXYZINE PAMOATE100 mg/1
Pharmacologic classes
Antihistamine [EPC]; Histamine Receptor Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0555-0324-02 | 00555032402 | 100 CAPSULE in 1 BOTTLE (0555-0324-02) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/06068fff-2e79-4721-bcc7-b0938aa20e7aNADAC price for package 00555032402
GET /v1/drugs/nadac/00555032402
Use it
Look up 0555-0324 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0555-0324 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0555-0324. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.